Navigation Links
Digirad Corporation to Release First Quarter Financial Results on April 30, 2009
Date:4/21/2009

Conference Call and Webcast Set for 11:00 a.m. ET

POWAY, Calif., April 21 /PRNewswire-FirstCall/ -- Digirad Corporation (Nasdaq: DRAD) will release before the market opens on Thursday, April 30, 2009, financial results for the first quarter ended March 31, 2009.

A conference call is scheduled for 11:00 a.m. ET on April 30 to discuss the results and management's outlook. The call may be accessed by dialing 800-762-8795 five minutes prior to the scheduled start time and referencing Digirad. For callers outside the United States, dial 480-629-9041. A simultaneous webcast of the call may be accessed online from the Events & Presentations link on the Investor Relations page at www.digirad.com; an archived replay of the webcast will be available within 15 minutes of the end of the conference call.

About Digirad

Digirad is a leading provider of diagnostic imaging products and services that improve patient care while driving positive healthcare economics. For more information, please visit www.digirad.com. Digirad(R), Digirad Imaging Solutions(R), and Cardius(R) are registered trademarks of Digirad Corporation.

    Investor Contact:
    Matt Clawson
    Allen & Caron
    949-474-4300

    Company Contact:
    Todd Clyde
    Chief Executive Officer
    858-726-1600


'/>"/>
SOURCE Digirad Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Digirad Receives 510(k) for Cardius X-ACT Rapid Cardiac SPECT/VCT Imager
2. Digirad Corporation Sells Arizona, Nevada Service Hubs
3. Digirad Names Richard B. Slansky Chief Financial Officer
4. Digirad Corporation Sells Northern California Service Hubs
5. Digirad Corporation to Release Fourth Quarter and Year-End Financial Results on February 5, 2009
6. Digirad Corporation Comments on Fourth Quarter Progress
7. Digirad Corporation CEO to Present at J.P. Morgan Healthcare Conference in San Francisco
8. Digirad Corporation Receives FDA 510(k) Clearance for nSPEED(R) Reconstruction Software for Improved Image Quality in Less Time With Less Radiation
9. Digirad Corporation Reports Financial Results for 2008 Second Quarter and Six Months
10. Digirad Corporation to Present at CapStone Small-Cap Investor Conference
11. Digirad Corporation to Present at Bank of America 2008 Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 25, 2017 , ... ProRehab Physical Therapy (PRPT) ... physical therapy provider for Derby City CrossFit, effective immediately. , In addition to ... and effectively as possible, ProRehab’s sports physical therapists will work with athletes to ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report ... score performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, ... highlights important patterns in student test score performance, the report’s limited analyses fail ...
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are ... help with process innovation in drug formulation and manufacturing. CoreRx offers its ... analytical equipment in support of their development and manufacturing goals. , The ...
(Date:4/25/2017)... , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing ... acute or chronic problems, I focus on preventative care with all my patients to alleviate ... any questions, always feel free to contact my office and my trained staff will assist ...
(Date:4/25/2017)... ... 2017 , ... Vetoquinol USA® , a world-class developer ... of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. ... level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Research and Markets has announced ... Market Prospects: Addressing Production Complexities Through Risk Management and ... ... Pipeline and Market Prospects: Overcoming Production Complexities Through Risk ... of the current trends in the global biosimilars market, ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: